The increasing incidence of genetic and rare diseases is a major factor driving revenue growth in the Antisense ...

The global Oligonucleotide Synthesis Market is valued at USD 7.78 Billion in 2024 and is projected to reach a value of USD 21 ...

Panelists discuss how exciting ongoing research efforts are expanding similar gene therapy technologies to other muscular ...

A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

Once dismissed as “junk,” a group of RNA molecules has been found to help regrow damaged nerves in mice in new research. The ...

Candida, a type of fungus, can spread throughout the body via the bloodstream, leading to organ damage and sepsis. Recently, ...

A mixed bag of top-line phase II data prompted stellar stock results for Prokidney Corp. and its chronic kidney disease (CKD) and diabetes therapy, rilparencel. There were statistically significant ...

Candida, a type of fungus, which can spread throughout the body via the bloodstream, leading to organ damage and sepsis.

Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...

Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides, aptamers and small interfering RNAs, and are typically ...

GSK’s antisense-based drug for chronic hepatitis B, bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval.

Look inside a brain cell with Huntington's disease or ALS and you are likely to find RNA clumped together. These solid-like clusters, thought to be irreversible, can act as sponges that soak up ...